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Abstract
Interest in biophysical studies on the interaction of antimicrobial peptides and lipids has strongly increased because of the
rapid emergence of antibiotic-resistant bacterial strains. An understanding of the molecular mechanism(s) of membrane
perturbation by these peptides will allow a design of novel peptide antibiotics as an alternative to conventional antibiotics.
Differential scanning calorimetry and X-ray diffraction studies have yielded a wealth of quantitative information on the
effects of antimicrobial peptides on membrane structure as well as on peptide location. These studies clearly demonstrated
that antimicrobial peptides show preferential interaction with specific phospholipid classes. Furthermore, they revealed that
in addition to charge-charge interactions, membrane curvature strain and hydrophobic mismatch between peptides and lipids
are important parameters in determining the mechanism of membrane perturbation. Hence, depending on the molecular
properties of both lipid and peptide, creation of bilayer defects such as phase separation or membrane thinning, pore
formation, promotion of nonlamellar lipid structures or bilayer disruption by the carpet model or detergent-like action, may
occur. Moreover, these studies suggest that these different processes may represent gradual steps of membrane perturbation.
A better understanding of the mutual dependence of these parameters will help to elucidate the molecular mechanism of
membrane damage by antimicrobial peptides and their target membrane specificity, keys for the rationale design of novel
types of peptide antibiotics. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The interaction of peptides with membranes has
been a subject of interest in membrane biophysics
for a number of years. Such studies have been ap-
plied for peptides corresponding to segments of
membrane proteins, for the purpose of understand-
ing the mechanism of action of membrane-active
peptides as well as for designing peptides which can
modulate membrane properties. Interest in the latter
research area has increased recently because of the
dramatic increase in the number of bacteria which
are resistant to conventional antibiotics [1,2]. This
health issue has been one of the dominant concerns
in the last few years of the World Health Organiza-
tion, who published a retrospective warning on the
occasion of the World Health Day in 1997. In par-
ticular, in the ¢eld of hospital infection control, there
is increasing concern regarding both the rapid emer-
gence of resistant strains with high epidemic poten-
tial and the fact that bacteria show reduced suscept-
ibility to vancomycin, a drug of last resort, as e.g.
described for a methicillin resistant clinical strain of
Staphylococcus aureus [3]. There are reports of about
a dozen new drugs that show promising antibacterial
activity by interfering with protein synthesis, cell wall
formation or DNA replication, but in the long run
these drugs are not likely to overcome resistance [4].
Therefore, urgent action is needed to develop novel
antibiotic agents [5].
One alternative approach is based on host defense
peptides of around 15^40 amino acid residues which
have evolved in nature to contend with invaders as
an active system of defense [6]. Important stimula-
tion in the ¢eld of innate immunity came from the
pioneering work of Erspamer [7], isolating a great
variety of di¡erent classes of pharmacologically ac-
tive molecules in frog skin and from the discovery of
magainins, peptide antibiotics from the skin of the
South African clawed frog Xenopus laevis [8], the
isolation of the ¢rst pure antibacterial factor from
insects [9] as well as from the discovery of antimicro-
bial peptides from mammalian white blood cells [10].
The biological activity of host defense peptides
mostly stems from their ability to perturb the lipid
bilayer structure of membranes, i.e. their barrier
function, and is not related to binding to a speci¢c
membrane receptor site. Support for this argument
comes from studies on synthetic melittin, magainin
and cecropins with all the amino acids in the D con-
¢guration. It has been shown that the all-D peptides
exhibit antibacterial and hemolytic activity identical
to that of the naturally occurring L forms [11]. The
molecular mechanism underlying this membrane
damage is, however, still a matter of debate [12].
Moreover, host defense peptides often exhibit a
high speci¢city towards their target membrane, i.e.
some of these peptides are toxic to humans, while
others have toxicity which is restricted to microor-
ganisms. These latter antimicrobial peptides often
exhibit a higher activity against certain microorgan-
isms than against others and in addition may also
lyse mammalian cell membranes. Therefore, the elu-
cidation of the speci¢c target membrane damaging
properties of these peptides is supposed to be a key
for the rationale design of novel types of peptide-
antibiotics, which should selectively lyse bacterial
membranes. This is likely to be accomplished only
if the molecular basis of the action of these peptides
is known.
Therefore, in order to gain insight into the specif-
icity towards particular lipid components exhibited
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by lytic peptides the di¡erences in architecture of
eucaryotic and procaryotic cell membranes (e.g.
[13]), which di¡er markedly in their lipid composi-
tion, have to be taken into account. The cell envelope
of Gram-negative bacteria is more complex, consist-
ing of an inner and an unique outer membrane,
which has a distinctive highly asymmetric composi-
tion with the lipopolysaccharides being located exclu-
sively in the outer layer and phospholipids being
con¢ned to the inner layer of the outer membrane.
Studies with the antimicrobial peptides magainin
[14,15] and defensin [16] showed that these peptides
can permeabilize this outer membrane and are able
to cross this barrier gaining access to the inner mem-
brane. The inner (cytoplasmic) membrane is essen-
tially a bilayer of lipids like the cytoplasmic mem-
brane of Gram-positive bacteria. There exists well
documented information concerning the phospholip-
id composition of individual genera and species of
Gram-negative and Gram-positive bacteria [17,18].
Although changes in lipid composition may occur
depending on environmental conditions, the concept
of a typical lipid composition of cell membranes is
well accepted. In addition, the phospholipid and gly-
colipid composition from one group to another may
vary to a larger extent for Gram-positive bacteria
than for Gram-negative ones. A common feature in
any case is the presence of large amounts of nega-
tively charged phospholipids and PE. The phospho-
lipid composition of some selected microorganisms
are given in Table 1, which indicates that in general
higher amounts of PE are found in the inner mem-
brane of Gram-negative bacteria as compared to the
cytoplasmic membrane of Gram-positive bacteria.
For example, PG and its derivatives are the only
phospholipids of the membrane of S. aureus, while
PE is the dominant component (82%) of the inner
(cytoplasmic) membrane of Escherichia coli. On the
other hand, in human erythrocyte membranes, which
can be considered representative for mammalian cell
membranes, the choline phosphatides, PC and SM,
occur predominantly in the external lea£et, whereas
the aminophosphatides, PE and PS, are found al-
most exclusively in the inner lea£et of the bilayer
(Table 2). While a wealth on information has been
gained on the interaction of lytic peptides with PC
membranes, only recently has the number of studies
utilizing other phospholipids increased. A set of se-
lected examples for peptide interactions with such
liposomes, using primarily data gained by di¡erential
scanning calorimetry and X-ray techniques, which
yields information on the e¡ects of the antimicrobial
peptides on both the organization of the lipids and
morphology of the model systems, will be presented.
2. Lipid discrimination by antimicrobial peptides as
probed by DSC
There is evidence that some antimicrobial peptides
have speci¢city for particular membrane lipid com-
ponents. For example, the peptide cinnamycin ap-
pears to have speci¢city for PE [19] and sapecin
exhibits a speci¢c a⁄nity for cardiolipin [20]. Gener-
Table 1
Phospholipid composition of Gram-positive and Gram-negative
bacteria
Species Phospholipid composition (w%)
PG PE CL+lysoPG Others
Gram-positivea
S. aureus 57 0 43 0
Staphylococcus epidermidis 90 0 1b 9
Bacillus megaterium 40 40 5b 15
Bacillus subtilis 29 10 47b 14
Gram-negativea
E. coli 6 82 12b 0
Salmonella typhimurium 33 60 7b 0
Pseudomonas cepacia 18 82 0 0
aIn percentage of total phospholipid of cytoplasmic membrane.
bOnly CL (cardiolipin) ; data adapted from [17,18].
Table 2
Phospholipid composition (% of lipid phosphorus) of human er-
ythrocyte membranes and their dominant localization (e.g.
[117])






Phosphatidic acid 2.2 inner
aAbout 1/3 is comprised by the alkenyl analog, ethanolamine
plasmalogen, which was shown to promote the formation of
non-bilayer structures [58,59].
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ally, antimicrobial peptides show preferential interac-
tion with negatively charged phospholipids as dem-
onstrated e.g. for magainins, which e¡ectively per-
meabilize PG-rich membranes and kill more
e¡ectively bacteria whose inner membranes contain
higher amounts of PG ([21]; Matsuzaki, this issue).
Recently, high-sensitivity di¡erential scanning calo-
rimetry studies were performed to gain insight on
the impact of the membrane structure regarding the
lytic activity of antimicrobial peptides, i.e. to under-
stand their target cell speci¢city. Such thermodynam-
ic studies allow one to investigate the in£uence of the
peptides on the phase transition properties of mem-
brane systems, from which the nature of lipid-peptide
interactions can be assessed [22,23].
McElhaney and coworkers recently studied the ef-
fects of the antimicrobial peptide gramicidin S on the
thermotropic phase behavior of large multilamellar
vesicles of DMPC, DMPG and DMPE by high-sen-
sitivity di¡erential scanning calorimetry [24]. The re-
sults demonstrated that the e¡ects varied markedly
with the structure and the charge of the lipid polar
headgroup. DMPE showed only small reduction in
the temperature, enthalpy and cooperativity of the
gel to liquid-crystalline phase transition after the li-
posomes have been exposed to high temperatures.
Similarly, DMPC vesicles showed modest decreases
in the temperature, enthalpy and cooperativity,
although the pretransition is abolished. Exposure to
high temperatures is not required to observe these
e¡ects. In contrast, gramicidin S has a much greater
e¡ect on the phase behavior of the anionic DMPG
by substantially reducing the temperature, enthalpy
and cooperativity of the main phase transition and
abolishing the pretransition at lower peptide concen-
trations as compared to DMPC.
Furthermore, microcalorimetry was used to study
the e¡ects of the human neutrophil peptide, HNP-2
[25], on the thermotropic behavior of liposomes
mimicking bacterial and erythrocyte membranes
[26]. In this study the lipid composition of the lipo-
somes represented the major phospholipid compo-
nents of these cell membranes: PE and the negatively
charged PG for bacterial membranes, and the zwit-
terionic PC and SM for erythrocyte membranes. In
the presence of this antimicrobial peptide, which ex-
hibits a triple stranded L-sheet con¢guration [27], the
phase behavior of liposomes containing negatively
charged phosphatidylglycerol was markedly altered.
Already at very low peptide concentrations (lipid-to-
peptide molar ratio of 500:1), a slight shift of the
phase transition temperature and the occurrence of
a shoulder was observed. Addition of HNP-2 to li-
posomes mimicking bacterial membranes, i.e. PE/PG
mixtures, resulted in phase separation presumably
into peptide-rich and -poor domains. The preference
for negatively charged membrane surfaces is also in
accordance with vesicle leakage experiments [28], as
had been proposed by White et al. [29]. In this re-
spect it is interesting to note that leakage experiments
showed that in the case of rabbit defensin, cardioli-
pin seems to be essential for creating lesions as no
leakage was observed for liposomes composed of PE
and PG. On the other hand, HNP-2 did not a¡ect
the phase behavior of membranes mimicking eryth-
rocyte membranes (equimolar mixtures of PC and
SM) as well as of the pure lipids. Moreover, a
similar behavior has been observed with the antimi-
crobial peptides peptidyl-glycine-leucine-carboxy-
amide (PGLa) from the skin secretion of the frog
Fig. 1. Excess heat capacity functions of DPPG/DPPE lipo-
somes (broken line) in the presence of PGLa (solid line) at a
lipid-to-peptide molar ratio of 100:1 (top, DPPG/DPPE 1:1
mol/mol; bottom, DPPG/DPPE 1:3 mol/mol). Experiments
were performed in 10 mM Na-phosphate bu¡er, pH 7.4 at a
scan rate of 0.25‡C/min.
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X. laevis [30] and protegrin-1 [31], isolated from pork
leukocytes, despite their di¡erent secondary struc-
tures. While PGLa was shown to adopt an K-helical
structure in the presence of negatively charged phos-
pholipids [30,32], a hairpin-like L-sheet structure was
reported for protegrin-1 [33]. Again phase separation
was observed in liposomes that contained negatively
charged phospholipids. In mixtures of PGLa and
DPPE/DPPG this e¡ect was manifested by a minor
transition at low temperatures and a shift of the
larger one to slightly higher temperatures (Fig. 1).
Concomitantly, a slight increase of cooperativity
was detected [34]. These results suggest that the pep-
tide forms speci¢c domains with the negatively
charged PG, thereby decreasing the amount of PG
in the peptide-poor domains and hence inducing the
temperature shift owing to the increased content of
PE in these domains. This is supported by the fact
that in DPPG/PGLa mixtures, a second, relatively
high cooperative transition was found at elevated
temperature in addition to the main transition of
DPPG (Fig. 2). In contrast to the pure lipid, no
pretransition was found for the peptide-a¡ected do-
mains, indicating an untilting of the hydrocarbon
chains which is due to membrane penetration of
the peptide in accordance with wide-angle X-ray
measurements [30]. Moreover, analysis of the enthal-
py of peptide-rich and -poor lipid domains revealed
that a distinct fraction of PG is associated with
PGLa. Using lipid-speci¢c £uorescent probes it was
shown that amphipathic helical, membrane active
peptides of the A- and L-type [35] were also able
to induce phase segregation in zwitterionic-acidic lip-
id mixtures (PC/PG), most likely owing to preferen-
tial association with the negatively charged lipid [36].
Further, it was suggested that peptide-lipid charge-
charge interactions were capable of modulating ex-
isting domain composition in the course of the main
phase transition in this mixture.
As discussed recently by Epand [37], the role of the
lateral organization of the complex lipid mixture in
membranes upon the interaction of lytic peptides
should be considered. Although in a £uid membrane
segregation of lipids is rarely observed, lateral do-
main organization of biological membranes is
thought to be of physiological relevance. One exam-
ple for a possible phase separation in the liquid-crys-
talline phase comes from DSC measurements on the
LK-HII phase transition of dipalmitoleoyl phosphati-
dylethanolamine (DiPoPE) in the presence of magai-
nin 2. These traces showed a minor and a major
peak, which is shifted to higher temperatures with
increasing amounts of peptide, suggesting the occur-
rence of peptide-rich and peptide-depleted domains
[38]. Furthermore, very recently Uragami et al. [39]
have provided evidence by use of nearest-neighbor
recognition methods that in bilayers the headgroup
mismatch between PG- and PE-like lipids is su⁄cient
to induce lateral heterogeneity in the £uid phase.
Immiscibility was also found by DSC experiments
to exist in the lamellar gel phase in DPPG/DPPE
mixtures between 5 and 40 mol% of DPPE [40]. In
this concentration range a phase separation of highly
enriched DPPG was observed. These e¡ects were ex-
plained as a consequence of the molecular shape of
the phospholipids di¡ering markedly in their head-
group properties as well as the packing characteris-
tics of the hydrocarbon side chains. The e¡ective
area of the PG headgroup is larger than predicted
by its geometrical size owing to electrostatic repul-
sion (e.g. [41]) and therefore the cross-sectional area
of the headgroup matches the hydrophobic cross-sec-
tional area. In contrast, PE exhibits a smaller head-
group area as compared to the cross-sectional area
required by the acyl chains. Moreover, adjacent PE
lipids interact intermolecularly by hydrogen bonding
between the amino and phosphate groups, which fa-
vors a close lipid packing [42]. Therefore, PE will
Fig. 2. Excess heat capacity functions of DPPG liposomes in
the presence of PGLa at a lipid-to-peptide molar ratio of 50:1.
Experiments were performed in 10 mM Na-phosphate bu¡er,
pH 7.4 at a scan rate of 0.25‡C/min. Deconvolution of data is
indicated; experimental data (solid line), ¢tted overall (broken
line) and individual components (dotted line).
BBAMEM 77748 30-11-99
K. Lohner, E.J. Prenner / Biochimica et Biophysica Acta 1462 (1999) 141^156 145
tend to adopt structures with higher intrinsic curva-
ture, while PG will rather form £at lamellar lipid
aggregates.
It can be assumed that the molar ratio of PG and
PE may be important in determining microscopic
di¡erences in their lateral organization, packing
and/or mobility, which can be ampli¢ed by the inter-
action with other membrane constituents and in par-
ticular by interaction with membrane-active solutes
in the environment. Evidence for this comes from
studies on the insertion of alamethicin into model
membranes composed of PC and PE with identical
acyl chains, which depended strongly on the molar
ratio of these lipids, emphasizing again the impor-
tance of the lipid headgroup packing [43]. These au-
thors also concluded that the speci¢c physical char-
acteristics of the phospholipids, i.e. the cross-
sectional area of the lipid headgroup and the hydro-
carbon side chains, are important factors in deter-
mining whether and how the lipid bilayer will be
a¡ected by membrane-active peptides. These obser-
vations further emphasize that the headgroup struc-
ture and composition may be important in de¢ning
the two-dimensional organization in membranes and
it can be expected that further studies focusing on
this aspect will help to elucidate the role of the phos-
pholipid matrix in the interaction between mem-
branes and antimicrobial peptides.
3. The role of membrane spontaneous curvature in
peptide interaction
Both phosphatidylglycerol and phosphatidyletha-
nolamine are major phospholipid components in
bacterial plasma membranes as described earlier.
As mentioned above PE is characterized by a cone-
shaped molecular geometry [44,45] and possesses a
large spontaneous curvature [46]. This property
makes PE prone to form nonlamellar structures.
Such lipids can also comprise a large fraction of
other biomembranes [47]. The importance of the
proper balance between lamellar and nonlamellar
phase forming lipids has been widely discussed [48^
50]. The presence of the latter signi¢cantly increases
membrane monolayer curvature stress, thereby con-
ferring upon cell membranes a degree of nonlamel-
lar-forming propensity, which is believed to be es-
sential for normal membrane function such as
membrane fusion (e.g. [51^55]). It has also been sug-
gested that the presence of nonlamellar-preferring
phospholipids in bilayer membranes induces a frus-
trated curvature stress, which in turn may a¡ect the
conformational state and hence the activity of mem-
brane proteins [56]. Moreover, Richard and Raquel
Epand demonstrated that this curvature strain can
provide energy for certain membrane processes [57].
They showed that incorporation of a few percent of
lysophosphatidylcholine into large unilamellar
vesicles of monomethylated PE at neutral pH is an
exothermic process as detected by calorimetry corre-
sponding to the relief of curvature strain in bilayers
having the tendency to convert to the inverse hexag-
onal phase. These observations suggest that consid-
erable energy may be released upon incorporation of
amphipathic peptides into membranes which have a
low radius of spontaneous curvature.
The e¡ect of peptides on membrane spontaneous
curvature can be evaluated on the basis of their e¡ect
on the lamellar (LK) to inverse hexagonal (HII) phase
transition temperature (TH) as detected by calorim-
etry. This will yield information on the bilayer (de)-
stabilizing property of amphipathic peptides, which
is helpful in elucidating the mechanism of membrane
damage by lytic peptides. Such DSC studies are usu-
ally performed with liposomes composed of phos-
phatidylethanolamines which are prone to adopt
the HII phase (e.g. [44,58,59]). Frequently, DiPoPE
has been used because it exhibits a TH of 43‡C,
which allows convenient detection of temperature
shifts induced by antimicrobial or cytolytic peptides.
It should be noted that although lamellar gel to
liquid-crystalline phase transitions are easily detected
by DSC owing to their large enthalpy change, prob-
lems may arise with the detection of the less cooper-
ative and enthalpic lamellar to nonlamellar phase
transitions despite the use of high sensitivity instru-
ments. For example, the enthalpy for the LK-HII
phase transition of DOPE is around 0.3 kcal/mol
[60] and even less for the LK-QII transition of mono-
methylated DOPE [61]. Hence, the observation of
nonlamellar phases may require additional techni-
ques like 31P-NMR and X-ray di¡raction to detect
such phases and the latter technique has the advant-
age that the supramolecular structure of the lipid
aggregates can be assigned in detail [62].
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Initial studies were performed with the 18L model
peptide, which features the consensus sequence aver-
aged from a number of naturally occurring lytic am-
phipathic K-helical peptides [35], and Ac-18A-NH2,
an 18 amino acid residue peptide that mimics K-hel-
ical segments of exchangeable human plasma apoli-
poproteins [63]. Based on the di¡erence in the
charged residue distribution on the polar face of
the K-helix, a cross-sectional molecular shape con-
cept, de¢ning class A (e.g. apolipoproteins) and class
L (lytic) peptides, was postulated, by which mem-
brane stability might be controlled [64]. In fact, it
was found that class L peptides and or class A pep-
tides have opposite e¡ects on the LK-HII phase tran-
sition temperature of DiPoPE, i.e. the former low-
ered and the latter raised TH. By analogy to the
reciprocal e¡ects of the molecular shape of phospho-
lipids on membrane structure, it was proposed that
the inverted wedge shape of class L helixes destabil-
izes such membranes, while the wedge shape of class
A helixes stabilizes the PE bilayer [65].
It was also shown that the wasp venom peptide,
mastoporan [64], as well as the antimicrobial peptide
magainin 2 [38], shifted TH to higher temperatures.
DSC data revealed that already very low magainin
concentrations strongly raised the TH of DiPoPE
(1.8‡C at a lipid-to-peptide molar ratio of 1000:1).
A similar behavior was reported for magainin ana-
logs [66]. These ¢ndings are interesting in view of a
possible mechanism of membrane lysis by the anti-
microbial peptide magainin (see also chapter by Mat-
suzaki), which binds selectively to negatively charged
phospholipids. There is evidence that the peptide
forms a dynamic peptide-lipid supramolecular com-
plex pore [38,67]. Interestingly, permeabilization of
lipid bilayers composed of PG occurred at a lipid-
to-peptide molar ratio of about 100:1, while perme-
abilization of bilayers composed of other negatively
charged lipids such as PS, PA, and cardiolipin (CL),
occurred at much higher peptide concentrations (lip-
id-to-peptide molar ratios of 50:1 to 10:1). The latter
three classes of phospholipids are known to be able
to adopt inverse hexagonal structures under condi-
tions of reduced interlipid electrostatic repulsions.
Moreover, incorporation of PE also inhibited the
magainin-induced pore formation. These results
were explained by postulating that the peptide im-
poses a positive curvature in the bilayer, facilitating
the formation of the pore of a torus type, and there-
fore the pore formation is inhibited by the presence
of negative curvature-inducing lipids [38]. Thereby, it
was found that PEs, exhibiting the largest hydropho-
bic cross-section, were most e⁄cient at inhibiting
pore formation [38], which can be correlated with
their higher ability to promote nonlamellar structures
[55].
A direct correlation between the hemolytic activity
of magainin analogs and their potency to raise the
lamellar to inverse hexagonal phase transition tem-
perature was reported [66]. Also N-lysin, a hemolytic
peptide from S. aureus, which cannot be unambigu-
ously classi¢ed to the scheme of Segrest of amphi-
pathic helixes [35], was shown to increase TH of Di-
PoPE to a similar extent than magainin (1.5‡C at a
lipid-to-peptide molar ratio of 1000:1) [68]. More-
over, similar to magainin 2 the phase transition
was hardly discernible above 0.2 mol% of peptide.
The high sensitivity of this phase transition to very
small amounts of incorporated amphipathic peptides
is shown in Fig. 3. In analogy to observations with
melittin, which like N-lysin consists of a single poly-
peptide chain of 26 amino acids and a cationic car-
boxyl terminal end, the interaction of N-lysin with PE
can be explained based on the molecular shape of
phospholipids. As shown for melittin, the tendency
towards the formation of discoidal structures can be
counterbalanced by the HII phase preference of PE
[69], being consistent with a relief of the lateral pres-
sure of the hydrocarbon chains, which in turn will
Fig. 3. E¡ect of staphylococcal N-lysin on the LK-HII phase
transition temperature of DiPoPE as determined by high-sensi-
tivity DSC experiments.
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result in a stabilization of the bilayer structure. A
di¡erent behavior was found for melittin/dihexadecyl
PC mixtures indicating the impact of the nature of
the phospholipid matrix. There, above the chain
melting transition, X-ray scattering data were char-
acterized by a broad continuous transform with
superimposed peaks arising from nonlamellar struc-
tures [70]. In addition, this peptide/ether lipid system
was sensitive to swelling, increasing the fraction of
the broad continuous transform, suggesting a se-
quence of lamellar-cubic-micellar structure of type I
in agreement with predictions from general amphi-
phile/water binary phase diagrams [71].
On the other hand, the cyclic decapeptide grami-
cidin S, a bacterial peptide toxin from Bacillus brevis,
was found to decrease TH [72], i.e. owing to the
presence of gramicidin S the tendency of the phos-
phatidylethanolamine lipid bilayer to adopt struc-
tures with a negative curvature is increased, thus de-
stabilizing the lipid bilayer toward the formation of
nonlamellar structures. For example, the probable
existence of inverted cubic phases for a mixture of
DMPE and gramicidin S were proposed from supple-
mentary X-ray re£ections, which could not be in-
dexed on a lamellar phase [72]. Moreover, in the
presence of the peptide, the formation of isotropic
components were observed in the 31P-NMR spectra
of heterogeneous lipid mixtures such as occur in
Acholeplasma laidlawii B and E. coli membranes
[72]. The appearance of an isotropic signal in the
31P-NMR spectrum of aqueous phospholipid disper-
sions is observed for fast tumbling lipid aggregates,
like small unilamellar vesicles and micelles, or for
cubic or other three-dimensionally ordered inverted
nonlamellar phases. As 31P-NMR spectroscopy can-
not distinguish between these putative lipid-peptide
aggregates due to their fast tumbling in respect to the
31P-NMR time scale (e.g, [73^76]), these lipid aggre-
gates were further investigated by a more extensive
X-ray di¡raction study. These latter experiments
clearly showed that the interaction of gramicidin S
with the microbial lipid extracts promotes the forma-
tion of a nonlamellar structure, which could be iden-
ti¢ed as a bicontinuous cubic lipid phase of the space
group Pn3m [77]. As an example, Fig. 4 shows se-
lected di¡ractograms obtained for the total extract of
Fig. 4. Small-angle X-ray di¡ractograms of an aqueous dispersion of E. coli membrane total lipid extract (¢ve rear frames) and a mix-
ture of these lipids with gramicidin S at a lipid-to-peptide molar ratio of 25:1 (¢ve front frames). Data recorded from the ¢rst heating
(selected temperatures at 25, 35, 45, 60‡C are shown) and cooling to 25‡C are shown; s = 1/d = 2sin(3)/V, where V is the wavelength of
the X-ray beam and 23 the scattering angle.
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E. coli membrane lipids. The combination of X-ray
di¡raction and 31P-NMR spectroscopic data ac-
quired with these microbial lipid extracts is consis-
tent with the existence of a polydomain specimen in
which a lamellar phase coexists with the nonlamellar
phase. These observations indicate that gramicidin S
has considerable potential for disrupting the structur-
al integrity of lipid membranes by markedly decreas-
ing the energetic barriers against the formation of
inverted (i.e. type II) nonlamellar lipid phases. It is
therefore possible that interactions of these peptides
with lipid bilayers result in a signi¢cant increase in
monolayer curvature stress, a property that may well
be key to their membrane disruptive properties ([72]
and the gramicidin contribution in this issue by Pren-
ner et al.).
A recent study has shown that alamethicin exhibits
similar properties [78]. The e¡ect of alamethicin on
membrane spontaneous curvature was probed with
DEPE. Thereby, it was found that addition of as
low as 0.5% (w) peptide can induce the formation
of nonlamellar structures over a wide temperature
range. Phase assignment, based on the ratios of the
Bragg peaks, revealed again the occurrence of a cu-
bic phase of the space group Pn3m. X-ray di¡raction
further demonstrated that the lattice spacing of the
cubic phase did not change over an alamethicin con-
centration range of 1^10% (w). Moreover, it was
reported that the lattice spacings of the HII phase,
which was found to coexist with the lamellar phase
for some samples and temperatures, was not a¡ected
by the presence of the peptide. This can be due to the
fact that alamethicin is either expelled from the HII
phase or that incorporation of the peptide does not
alter the membrane spontaneous curvature. It was
suggested that this peptide may change the thickness
and/or £exibility of the bilayer, thereby inducing the
formation of the cubic phase. However, the authors
argue that the formation of such phases is still not
su⁄ciently understood that one would be able to
draw solid conclusions [78].
Finally, gramicidin A and C were shown to be
even able to promote HII phase formation in
DOPC, which is known to form only a lamellar
phase at physiologically relevant temperatures [79].
Both peptides, whereby the tryptophan in position
11 of gramicidin A is replaced by tyrosine in grami-
cidin C, induce to a similar extent this nonlamellar
phase. Distinct bands were found by sucrose density
centrifugation experiments which were analyzed by
X-ray di¡raction and 31P-NMR, demonstrating a
quantitative phase separation between a lamellar
phase and an HII phase, the latter being enriched
in peptide. Promotion of negative curvature by these
peptides was further shown by the conversion of ly-
sophosphatidylcholine micelles into bilayer structures
[80]. In addition, small angle X-ray di¡raction ex-
periments revealed that upon increasing the length
of gramicidin A, the peptide lost its ability to induce
HII phase formation indicating a requirement of hy-
drophobic mismatch between the peptides and the
lipid acyl chains [81]. This phenomenon was further
investigated systematically using gramicidin A and
hydrophobic K-helical transmembrane peptides that
resemble the gramicidin channel [82,83]. It was sug-
gested that the extent to which the length of the
membrane-spanning part of intrinsic membrane pro-
teins matches the hydrophobic core of the bilayer
may be an important factor in determining mem-
brane structure and function.
4. Membrane location of peptides and its e¡ect on
membrane structure
There is ample evidence that amphipathic peptides
can adopt a variety of membrane locations depend-
ing on various parameters, among which the phos-
pholipid composition and the peptide concentration
are two of the determinants. These aspects were
studied intensively by Huang and coworkers within
the last decade (see below). In a series of systematic
studies with antimicrobial peptides, they showed that
there exists a certain critical concentration for inser-
tion, ¢rstly described for alamethicin [84]. In general,
it seems that below this concentration the peptides
are aligned parallel to the membrane surface, while
above this concentration they are oriented perpendic-
ular to the membrane plane. Information on changes
in the bilayer structure caused by the peptide adsorp-
tion and/or insertion can be obtained from X-ray
di¡raction and also by neutron scattering. Very re-
cently White and coworkers demonstrated, using a
novel X-ray di¡raction method based on absolute-
scale re¢nement [85^87], that they can obtain quan-
titative information about the depth of penetration
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and orientation of peptides in lipid bilayers in the
liquid-crystalline phase [88]. So far, mostly bilayer
structures of low resolution have been obtained ow-
ing to the thermally disordered hydrocarbon chains.
This has been improved by the determination of the
position of speci¢cally labeled sites of the lipids, in
particular bromination of the double bonds of acyl
chains, which was shown to provide information
about the structure of the hydrophobic core and to
sense changes in bilayer structure [87]. This approach
was further extended by developing liquid crystallog-
raphy for the determination of complete one-dimen-
sional structures of liquid-crystalline bilayers [89,90],
which gives information on the positions of speci¢c
structural groups such as e.g. phosphate or carbonyl
groups and also on the transbilayer spatial distribu-
tions of water [91]. Based on the completely solved
structure of DOPC [86], changes in the brominated
double-bond distributions provided a basis for the
accurate determination of the transbilayer distribu-
tion of the class A amphipathic K-helical peptide
Ac-18A-NH2 in oriented multilamellar bilayer of
DOPC [88]. The di¡raction results showed that this
peptide was located in the bilayer interface close to
the glycerol moiety. Its bilayer distribution could be
described by a Gaussian function, whereby the width
is a measure of the diameter of the helix. These data
indicated that the amphipathic class A peptide pene-
trated the hydrocarbon core to about the level of the
phospholipid double bond. Moreover, a slight de-
crease in bilayer thickness with a concomitant shift
of the double-bond distribution toward the bilayer
center was observed arising from a small increase
in lipid-speci¢c area caused by the peptide.
These results are in accordance with earlier obser-
vations on alamethicin and magainin which also
demonstrated a decrease of the bilayer thickness
upon adsorption of the peptides to a membrane sur-
face. It was proposed that if the hydrophobic volume
of the phospholipids remains constant, the decrease
of bilayer thickness must be compensated by expan-
sion of the cross-sectional area of the lipid hydro-
carbon chains. For example, calculation of the area
expansion of the acyl chain region of diphytanoyl PC
in the presence of alamethicin revealed that it re-
mained constant for each adsorbed alamethicin mol-
ecule (280 þ 20 Aî ) below a lipid-to-peptide molar ra-
tio of 47:1 [92]. Interestingly, this area expansion
correlates approximately with the cross-sectional
area of one peptide molecule, which implies that
the lipid headgroups will separate laterally within
the membrane plane. The membrane thinning ob-
served in this concentration range was linearly de-
pendent on the peptide concentration. In a subse-
quent study, the coexistence range (adsorbed and
inserted peptide) as well as the insertion phase at
full lipid hydration, being relevant to the physiolog-
ical conditions, were investigated by X-ray di¡rac-
tion using oriented lipid bilayers [93]. These experi-
ments, which are critical to sample disorder as
discussed by the authors, showed that at high peptide
concentrations the bilayer thickness increased again
with the content of inserted alamethicin. This obser-
vation was explained by postulating that the hydro-
phobic region of the £uid diphytanoyl PC bilayer will
have to match the hydrophobic portion of the ala-
methicin molecule. Moreover, it was found that pep-
tide adsorption induced chain disorder over a large
area [92]. A long range e¡ect of amphipathic peptides
upon bilayer organization was also proposed from
earlier DSC and temperature scanning densitometry
studies on DPPC/melittin and DPPC/N-lysin mix-
tures, respectively [94,95]. Finally, it should be men-
tioned that neutron scattering in the plane of di-
lauroyl PC (DLPC) and diphytanoyl PC bilayers
revealed a pore structure of the barrel-stave type
for high alamethicin concentrations [93,96].
Further, it was demonstrated that magainin be-
haves in many aspects similarly to alamethicin,
such as exhibiting two distinct orientations when in-
teracting with a lipid bilayer depending on the crit-
ical concentration for peptide insertion, which
roughly correlates with the concentration required
for cytolytic activity [97] or membrane thinning be-
low this concentration [98]. It is important to empha-
size, however, that these experiments were performed
with PC/PS bilayers, as magainin interacts more
strongly with acidic phospholipids. However, in con-
trast to alamethicin, neutron in-plane scattering in-
dicated a di¡erent pore structure at high magainin
concentrations [99]. In agreement with suggestions of
Matsuzaki (for details see chapter by Matsuzaki in
this issue), a toroidal or wormhole model was pro-
posed on the basis of the scattering data. In this
model the lipid bends back on itself like the inside
of a torus, inducing a lateral expansion in the head-
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group region of the bilayer, the spaces of which are
¢lled by the peptide molecules in accordance with
earlier DSC data which indicated that magainin is
associated with the headgroups [100].
As has been reported for transmembrane proteins
and as outlined above upon membrane insertion of
antimicrobial peptides, one can expect that the pep-
tides may often display a di¡erent hydrophobic
length as compared to the hydrocarbon chains of
the lipid interacting with. It is now a commonly ac-
cepted idea that this hydrophobic mismatch between
phospholipids and peptides is compensated by ad-
justing the hydrophobic core of the lipid bilayer to
the hydrophobic length of the peptide [101,102]. Har-
roun et al. [103] emphasized that in order to under-
stand nonspeci¢c interactions of peptides and lipids,
it is important to consider the elastic properties of
these molecules. While lipid bilayers are very deform-
able owing to the £exibility of the hydrocarbon side
chains, at least globular proteins are rather rigid, the
thickness compressibility of lipid bilayers and the
volume compressibility of proteins, respectively, dif-
fering by two orders of magnitude [104,105].
Although one can assume that small amphipathic
peptides have a high degree of £exibility (see e.g.
Blondelle et al., this issue), it is conceivable that
when a peptide is inserted perpendicular to the mem-
brane surface, the lipid acyl chains will compensate
an eventual mismatch of the hydrophobic length be-
tween peptide and lipid. It was suggested that the
energy of the membrane deformation for hydropho-
bic matching is less than the energy cost of hydro-
phobic mismatch.
To test this idea, gramicidin D, known to form
well de¢ned dimeric channels in lipid bilayers [106],
was embedded in DLPC and DMPC bilayers at high
peptide concentrations (lipid-to-peptide molar ratio
of 10:1) and near full lipid hydration. In the liquid-
crystalline phase the bilayer thickness, i.e. the phos-
phate-to-phosphate distance of the opposite mem-
brane lea£ets, as determined with re¢ned methods
from X-ray lamellar di¡raction patterns [92,107,
108], was found to increase by 1.3 Aî for the
DLPC/gramicidin D mixture and to decrease by 2.6
Aî for the DMPC/gramicidin D mixture. Hence, the
peptide apparently stretches DLPC bilayers and thins
DMPC bilayers toward a common thickness of
32.4 þ 0.3 Aî owing to hydrophobic matching. It
was suggested that upon embedding peptides in a
membrane, hydrophobic matching creates a strain
¢eld in the lipid bilayer that in turn gives rise to a
membrane-mediated attractive potential between
peptides [103]. Therefore, membrane in-plane scatter-
ing with X-ray was applied to directly measure the
gramicidin-gramicidin correlation in the liquid-
crystalline phase of bilayers. The nearest-neighbor
separation of the peptide was calculated to be 26.8
Aî in DLPC bilayers but shortens to 23.3 Aî in
DMPC bilayers. These experiments clearly give evi-
dence for hydrophobic matching and membrane-
mediated peptide-peptide attractive interactions,
which were just recently theoretically analyzed by
the same authors [109]. In this paper they show
that these processes can be described with a simple
elasticity theory of membrane deformation, whereby
the energetics of deformation are expressed as a
function of bending rigidity and thickness compres-
sibility of the bilayer.
5. Bilayer disruption by amphipathic peptides
Structural and thermodynamic studies as described
above indicate that several steps are involved in the
process of peptide-lipid interaction leading ¢nally to
membrane perturbation and permeabilization. More-
over, they present evidence that bilayer defects and
pore formation do not represent distinct classes of
membrane-lytic motifs, but rather that there is a con-
tinual gradation from one to another. So far, the
‘carpet model’ ([110]; Shai, this issue) has not been
discussed in this respect, although some of the fea-
tures described before by X-ray and neutron scatter-
ing are in accordance with this model. Like pore
formation, this model suggests that at low peptide
concentrations the peptides accumulate at the bilayer
surface and that penetration of peptides occur by
reaching a threshold concentration, i.e. critical con-
centration for peptide insertion, at which the bilayer
surface is largely occupied by the peptide molecules.
At this high relative peptide level the lipid bilayer is
destabilized owing to massive peptide insertion, in-
ducing disruption of the gross bilayer structure. It is
even conceivable that pore formation is an intermedi-
ate step in this process (for details see Shai, this
issue). The mechanism by which antimicrobial and
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cytolytic peptides ¢nally damage the membrane will
be determined by the peptide and lipid structure. The
carpet model also implies that the membrane integ-
rity is strongly a¡ected by the peptides, comparable
to the action of detergents, with which amphipathic
peptides share some general properties.
Data gained on melittin and N-lysin seem to sup-
port the idea of gradual membrane perturbation.
Temperature scanning densitometry [94] and DSC
as well as X-ray studies [111] showed that melittin
has pronounced e¡ects on the phase behavior of
DPPC already at very low peptide concentrations
(lipid-to-peptide molar ratio of 1000:1), abolishing
the pretransition of the lipid at a DPPC/melittin mo-
lar ratio of about 100:1. Similar results were ob-
tained by DSC for N-lysin/DPPC mixtures [95]. Since
these e¡ects cannot be accounted for only by local
perturbations around the sites of interaction, long
range e¡ects beyond the immediate neighborhood
of the incorporated peptide are supposed to be in-
volved. This idea was supported by ultrasonic experi-
ments on melittin/DPPC [112]. These results were
discussed in terms of a local phase separation con-
cept, where the peptide-a¡ected domains create line
defects in an ordered lipid lattice. Such a defect-like
action of melittin or N-lysin at high lipid-to-peptide
molar ratios may be explained by shifting the perco-
lation balance [113] of gel- and £uid-like states that
may coexist. However, at high melittin concentra-
tions (lipid-to-peptide molar ratio of 15:1), disk-
shaped particles were found for DMPC/melittin mix-
ture [114], suggesting a detergent-like action under
these experimental conditions.
Very recently, the interaction of staphylococcal N-
lysin with multilamellar vesicles composed of dimyr-
istoylphosphatidylcholine has been more extensively
studied over the whole concentration range by spec-
troscopic and X-ray techniques as well as DSC [115].
Similarly to the DPPC/N-lysin system, the addition of
smaller quantities of peptide had little e¡ect on the
phase transition temperatures of DMPC bilayers, but
did a¡ect the cooperativity and enthalpy of the tran-
sitions. However, increasing the peptide concentra-
tion to molar lipid-to-peptide ratios lower than
125:1 promoted the formation of two populations
of lipid particles, as deduced from the occurrence
of a new phase transition, characterized by slightly
increased temperature and markedly reduced cooper-
ativity and enthalpy (Fig. 5). These two distinct frac-
tions could be separated by centrifugation. Small-an-
gle X-ray scattering measurements con¢rmed that the
pelleted fraction consists of multilamellar vesicles, as
can be deduced from the sharp Bragg re£ections,
while the form of the small-angle X-ray scattering
curves obtained from the supernatant with its broad
side maxima and minima was characteristic for par-
ticle scattering. It is worthwhile to note that these
results demonstrate that DSC is also capable of de-
tecting such morphological changes, albeit indirectly.
The experimental scattering curves were further ana-
lyzed by indirect Fourier transformation, which can
be interpreted as originating from particles with the
shape of a £at inhomogeneous lamellae, i.e. single
bilayer lipid aggregates. Detailed analysis of the X-
ray data showed that with increasing amounts of N-
lysin, initially formed unilamellar vesicles trans-
formed into disk-shaped lipid-peptide aggregates of
a diameter of about 14 nm and a bilayer thickness of
5.2 nm. Interestingly, a hydrodynamic radius of 6.9
nm, as estimated from gel ¢ltration experiments, was
reported for the disk-shaped particles of melittin/
Fig. 5. High-sensitivity DSC thermograms of mixtures of
DMPC and N-lysin at a lipid-to-peptide molar ratio of 30:1 re-
corded with a scan rate of 0.25‡C/min. Simulation of the sharp
(dashed line) and broad (thin solid line) component are indi-
cated.
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DMPC [114]. Moreover, modeling of the X-ray data
veri¢ed a discoidal lipid bilayer with a diameter of 12
nm, which is surrounded by a peptide ring of about
1 nm thickness. A respective model drawn by Ras-
mol is shown in Fig. 6, where the rim is composed of
partially displaced N-lysin dimers (data taken from
the Brookhaven Protein Databank 1DHL) oriented
perpendicular to the bilayer plane. However, it has to
be noted that the experimental approach and analy-
sis used did not allow to determine accurately the
orientation of the peptide helix in the disk-shaped
micelle, but was rather derived from the molecular
properties of the peptide and lipid molecules. These
data support the idea that lytic peptides may have
concentration-dependent e¡ects on the membrane
structure inducing bilayer perturbations of long-
range order at low peptide concentrations and exhib-
iting a detergent-like action at high peptide concen-
trations. Pore formation, as also reported for N-lysin
[116], is not necessarily in contradiction to this pro-
posal, but may be either a transient state or may
occur at distinct environmental conditions particu-
larly as function of the lipid class.
6. Conclusion
Di¡erential scanning calorimetry and X-ray dif-
fraction studies have provided evidence that antimi-
crobial peptides discriminate between di¡erent
classes of phospholipids. These peptides show pref-
erential interaction with negatively charged phospho-
lipids, major components of bacterial membranes,
while they show only minor e¡ects on the phase be-
havior of zwitterionic lipids such as PC and SM,
major components of mammalian membranes. This
is in contrast to cytolytic peptides like melittin or N-
lysin, which perturb PC bilayers already at very low
peptide concentrations. At high peptide concentra-
tions they exhibit detergent-like action. These obser-
vations are in accordance with results obtained by
other techniques which, however, have not been the
focus of this chapter but are dealt with by other
authors of this special issue. Furthermore, it was
shown that antimicrobial peptides can induce phase
segregation in mixed phospholipid systems contain-
ing negatively charged lipids.
DSC and X-ray di¡raction studies on the interac-
tion between antimicrobial and cytolytic peptides
with PE, another major component of bacterial
membranes, demonstrated that the peptides perturb
the PE bilayer by a di¡erent mechanism. This can be
explained by the molecular geometry of the lipid and
peptide molecules. While some peptides (e.g. magai-
nin, PGLa or N-lysin) impose a positive membrane
curvature strain, others (e.g. gramicidins, alamethi-
cin) amplify the intrinsic negative membrane curva-
ture strain of this lipid. The former e¡ect can lead to
the formation of peptide/lipid pores, the latter will
promote the formation of nonlamellar lipid struc-
tures. Both mechanism will result in massive mem-
brane perturbation. Moreover, novel X-ray di¡rac-
tion and in-plane scattering techniques have
revealed quantitative information on both the loca-
tion of the peptide and the related e¡ect on lipid
ordering and membrane structure. These results,
like e.g. membrane thinning, will signi¢cantly con-
tribute to a better understanding of the action of
antimicrobial peptides on the molecular level.
The wealth of information gained by these com-
plementary techniques will not only be helpful for
the understanding of the molecular mechanism(s) of
membrane perturbation, but also emphasize the role
Fig. 6. Model of a lipid disk surrounded by a N-lysin ring
drawn by Rasmol 2.6. The discoidal lipid bilayer (only half of
the PC molecules are shown) is circumscribed by 24 dimers of
N-lysin (K-helices are shown as rods, theoretical model of the
peptide dimer was taken from the Brookhaven Protein Data-
bank 1DHL).
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of the phospholipid matrix in this process. It can be
expected that the mutual knowledge accumulated in
the ¢eld of membrane biophysics and peptide chem-
istry will strongly enhance our understanding of the
membrane damage by antimicrobial peptides. This in
turn will facilitate the design of novel peptide anti-
biotics which are urgently needed because of the dra-
matic increase in the number of bacterial strains
being resistant to conventional antibiotics [5].
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